Lymphoma Chemotherapy

Chemotherapy-induced myelosuppression is identified as a key driver of fatigue in lymphoma patients. Patients receiving chemotherapy for lymphoma often experience a broad range of treatment-related and disease-specific symptoms. Chemotherapy remains the main treatment approach for remission or cure in lymphoma.